News

Myasthenia gravis (MG) can co-occur with premature ovarian failure (POF). Prompt and proper MG treatment, however, can help restore reproductive organ health, a recent report of two cases suggests. The case report, titled “Clinical characteristics and relationship between myasthenia gravis and premature ovarian failure: report of two…

High levels of PCO2 — a measure of the amount of carbon dioxide gas dissolved in blood — may be a useful biomarker for higher mortality risk in people with myasthenia gravis undergoing acute respiratory crisis, a study suggests. The study, titled “Myasthenic crisis treated in a…

The use of blood cholesterol-lowering medications called statins is linked to a small risk of myasthenia gravis (MG), according to a large World Health Organization database study. The study, “Statin‐induced myasthenia: a disproportionality analysis of the WHO’s VigiBase pharmacovigilance database,” was published in the journal Muscle&Nerve. Statins…

A new international consortium based in Paris, and funded largely by the 28-member European Union, intends to speed the diagnosis of rare diseases, while also accelerating the development of treatments for the 95% of such illnesses that currently don’t have one. The European Joint Programme on Rare Diseases (EJP…

Camurus AB and Ra Pharmaceuticals have signed an agreement to develop and manufacture a long-acting injectable formulation of zilucoplan for patients with complement-mediated disorders, such as generalized myasthenia gravis. Using Camurus’s proprietary FluidCrystal technology, the subcutaneously injected formulation will allow patients with complement-mediated disorders — such as…

People with myastenia gravis (MG) whose disease is refractory, or resistant, to conventional therapies, are more likely to have disease flare-ups, visit an emergency room, be hospitalized, or be admitted to an intensive care unit — using more healthcare resources — than patients with nonresistant MG, a U.S. study…

Muscle cells of myasthenia gravis patients produce large amounts of the programmed cell death ligand 1 (PD-L1) — a substance produced by different types of cells to prevent the overactivation of immune cells — which may affect how these patients’ immune systems work, a study says. The findings of…

Myasthenia gravis and multiple sclerosis (MS) may share immunological features, according to researchers who studied the rare case of a man who developed both illnesses. The case was described in the study “Co-occurrence of multiple sclerosis and myasthenia gravis: A case report and review of…

It wasn’t until Gordana Loleska’s son David was 14 years old that doctors in their native North Macedonia diagnosed his kidney, vision, and hearing problems as Alport syndrome. Although she had known for years that something was wrong, the news that David would battle a lifelong rare disease devastated…

In certain people whose myasthenia gravis (MG) has been in stable remission for a long time, using the immunotherapy Opdivo (nivolumab) to treat a relapsed lymphoma may be possible, researchers in Germany report. Their case study differs from others that linked treatment with immunotherapies like Opdivo to a higher risk of…